Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

HLN XNYS

Market Cap

38B

Short interest (May 15)

0.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.54%

↓ 10.6%

Available Shares

500K

↓ 27.3%

Price Chart

Company Overview

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Company Info

Exchange: NYSE
CIK: 0001900304
Asset Type: ADRC

Market Data

Market Cap: $38,485,584,610
Employees: 24,524
Status: Active

Short Interest

Current Borrow Fee 0.54%
Range: 0.51% - 0.57%
Available Shares 500K
Range: 400K - 750K

Recent Changes

Fee Change: ↑ 10.9%
Available Change: ↓ 17.9%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime